PH12013500917A1 - Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions - Google Patents

Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions

Info

Publication number
PH12013500917A1
PH12013500917A1 PH1/2013/500917A PH12013500917A PH12013500917A1 PH 12013500917 A1 PH12013500917 A1 PH 12013500917A1 PH 12013500917 A PH12013500917 A PH 12013500917A PH 12013500917 A1 PH12013500917 A1 PH 12013500917A1
Authority
PH
Philippines
Prior art keywords
diseases
conditions
compositions including
nutritional compositions
supporting resistance
Prior art date
Application number
PH1/2013/500917A
Inventor
Dattatreya Banavara
Cecilia Munoz
Anja Wittke
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/980,833 external-priority patent/US20120171164A1/en
Priority claimed from US12/980,825 external-priority patent/US20120172288A1/en
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of PH12013500917A1 publication Critical patent/PH12013500917A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present disclosure relates to the use of nutritional compositions including lactoferrin from a non-human source in supporting resistance to diseases or conditions. The method includes administering to a human a nutritional composition comprising a fat or lipid source, a protein source and lactoferrin produced by a non-human source.
PH1/2013/500917A 2010-12-29 2011-12-15 Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions PH12013500917A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/980,833 US20120171164A1 (en) 2010-12-29 2010-12-29 Use of nutritional compositions including lactoferrin in supporting resistance to viral respiratory tract infections
US12/980,825 US20120172288A1 (en) 2010-12-29 2010-12-29 Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
PCT/US2011/065229 WO2012091945A1 (en) 2010-12-29 2011-12-15 Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions

Publications (1)

Publication Number Publication Date
PH12013500917A1 true PH12013500917A1 (en) 2024-06-03

Family

ID=45507878

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2013/500917A PH12013500917A1 (en) 2010-12-29 2011-12-15 Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions

Country Status (13)

Country Link
EP (1) EP2658389A1 (en)
CN (2) CN107668721A (en)
BR (1) BR112013015458A2 (en)
CA (1) CA2823018A1 (en)
EC (1) ECSP13012799A (en)
HK (1) HK1250608A1 (en)
MX (1) MX2013005943A (en)
PE (1) PE20141826A1 (en)
PH (1) PH12013500917A1 (en)
RU (1) RU2013134133A (en)
SG (1) SG190780A1 (en)
TW (1) TW201306760A (en)
WO (1) WO2012091945A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20122152A1 (en) 2012-12-17 2014-06-18 Progine Farmaceutici S R L COMPOSITION FOR TOPICAL USE.
US9609888B2 (en) * 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US20160015068A1 (en) * 2014-07-16 2016-01-21 Mead Johnson Nutrition Company Nutritional formulas containing oil blends and uses thereof
EP2992894A1 (en) 2014-09-05 2016-03-09 Progine Farmaceutici Srl Vaginal formulations for preventing and treating vaginal and cervico-vaginal infections
IT201600128713A1 (en) * 2016-12-20 2018-06-20 Frima Res Srls COMPOSITION IN THE TREATMENT OF INFLAMMATORY ANEMIA OR FROM FLOGOSIS FROM CHRONIC DISEASE
WO2022091023A1 (en) * 2020-11-02 2022-05-05 Apharm Srl Combination of active ingredients, compositions containing it and their use to sustain and strengthen the immune system
CN115886073A (en) * 2022-04-01 2023-04-04 北京三元食品股份有限公司 Fermented milk

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
DE69231793T2 (en) 1991-01-24 2001-11-08 Martek Corp., Columbia MICROBIAL OILS AND THEIR USE
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
CA2183459A1 (en) 1994-02-16 1995-08-24 Jan H. Nuijens Isolation of lactoferrin from milk
AU2003218623B2 (en) 2002-03-07 2008-01-17 Upfront Chromatography A/S A process of isolating lactoferrin
US20070191264A1 (en) * 2005-05-05 2007-08-16 Bristol-Myers Squibb Company, A Delaware Corporation Methods for inhibiting the growth of bacteria
CN101247823A (en) * 2005-05-05 2008-08-20 布里斯托尔-迈尔斯斯奎布公司 Use of bovine lactoferrin in the preparation of medicines for inhibiting bacterial growth
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
JP2009513572A (en) * 2005-09-28 2009-04-02 ベントリア バイオサイエンス Oral composition for intestinal disorders and / or diarrhea
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2008047391A1 (en) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Nutriceutic composition comprising lactoferrin and proteasic probiotics
CN101130079A (en) * 2007-07-19 2008-02-27 浙江省中医药研究院 Application of lactoferrin in preparation of medicine for preventing and treating diseases caused by human rotavirus
CN103054029B (en) * 2007-11-26 2015-06-24 雀巢产品技术援助有限公司 Age-tailored nutrition system for infants
ITRM20080163A1 (en) * 2008-03-26 2009-09-27 Maurizio Acri USE OF LATTOFERRINA FOR THE PREVENTION OF NEONATAL SEPSIS IN PREMATURED NEWBORNS
MY173944A (en) * 2009-10-29 2020-02-28 Nestec Sa Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof

Also Published As

Publication number Publication date
BR112013015458A2 (en) 2016-08-09
EP2658389A1 (en) 2013-11-06
SG190780A1 (en) 2013-07-31
CA2823018A1 (en) 2012-07-05
RU2013134133A (en) 2015-02-10
MX2013005943A (en) 2013-10-01
ECSP13012799A (en) 2013-10-31
CN107668721A (en) 2018-02-09
CN103429092A (en) 2013-12-04
HK1250608A1 (en) 2019-01-11
PE20141826A1 (en) 2014-12-17
TW201306760A (en) 2013-02-16
WO2012091945A1 (en) 2012-07-05

Similar Documents

Publication Publication Date Title
PH12015501751A1 (en) Nutritional compositions containing an enriched lipid fraction and uses thereof
IN2012DN00486A (en)
PH12013500917A1 (en) Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
PH12013501877A1 (en) Nutritional compositions including branched chain fatty acids and methods of using same
PH12012502318A1 (en) Substantially clear nutritional liquids comprising calcium hmb and soluble protein
AU2013312359A8 (en) Genetically modified non-human animals and methods of use thereof
EA201070419A1 (en) COMPOSITION FOR REGULATING METABOLISM OF LIPIDS
IN2014KN02830A (en)
TN2012000511A1 (en) Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
MY182593A (en) Composition containing chitin and digestible proteins
PH12014500516A1 (en) Whey protein micelles to enhance muscle mass and performance
PH12015501688B1 (en) Nutritional compositions containing magnesium threonate and uses thereof
PH12013500716A1 (en) Age-tailored nutritional composition with animal fats and vegetable fats
PH12012501704B1 (en) Nutritional compositions
AU2018201444B2 (en) High fat human milk products
MY183250A (en) Pediatric nutritional composition with milk peptides for healthy growth and development
PH12014502288A1 (en) Ready to drink beverages and methods of making thereof
MY174494A (en) Method for inhibiting pathogens using a nutritional composition
MX2013006741A (en) Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof.
WO2015095570A3 (en) Nutritional composition comprising hydrolyzed protein
WO2013184879A3 (en) Pumpable fat compositions
PH12016501390A1 (en) Nutritional compositions containing ceramide
MY187748A (en) Compositions and method for maintaining/improving cognitive function
UA109662C2 (en) PHARMACEUTICAL AND / OR DIETARY COMPOSITIONS BASED ON SHORT-CHAIN fatty acids
TR200801492A2 (en) Specially prepared honey kadayif.